Inventor

GARST MICHAEL E

US196 patents

⚠️ This page may combine multiple inventors who share the name “GARST MICHAEL E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GARST MICHAEL E

ALLERGAN INC

Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Injectable therapy for control of muscle spasms and pain related to muscle spasms

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Imidiazoles having reduced side effects

(2-hydroxy)ethyl-thioureas useful as modulators of α2B adrenergic receptors

Methods and compositions for modulating alpha adrenergic receptor activity

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) Quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Kinase inhibitors for the treatment of disease

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidone

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives

1,11-diesters of prostaglandin-F2α having a polar ester group at C-1

Substituted thiazole sulfonamides as antiglaucoma agents

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators

Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases

Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators

Sulfur derivatives as chemokine receptor modulators

Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators

2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators

ALLERGAN SALES INC

Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Ocular treatment using cyclosporin-A derivatives

Ocular treatment using cyclosporin-A derivatives

Combinations of prostaglandins and brimonidine or derivatives thereof

Anti-angiogenic agents

Methods of treating pain and other conditions

Methods and compositions for modulating alpha adrenergic receptor activity

Methods and compositions for modulating alpha adrenergic receptor activity

Cyclopentane (ene) oic acid, 2-alkenyl derivatives as therapeutic agents

BEARD RICHARD L

Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity

1-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators

UNIV CALIFORNIA

Prodrugs of proton pump inhibitors

ALLERGAN SALES LLC

Organosilyl compounds having nuclear hormone receptor modulating activity

PARTNERSHIP OF MICHAEL E GARST

Prodrugs of proton pump inhibitors